baber/WOPTO huggingface dataset:
Patent NZ-503598-A (NZ)
Title: Hydroxylated gemfibrozil, atorvastatin and fluvastatin with antioxidant activity for inhibition of lipoprotein oxidation
Inventor: AVIRAM MICHAEL
IPC: A61P39/04
Filed: 1998-11-04
Abstract: Hydroxylated derivatives of cholesterol lowering agents inhibit the oxidation of lipoproteins, and are thus useful for preventing the progression of atherogenesis and resultant vascular diseases, including heart attacks.
Patent NZ-509999-A (NZ)
Title: Tire inspection equipment
Inventor: ALEXANDER BRUCE M
IPC: G01M17/02
Filed: 1999-06-25
Abstract: Apparatus and methods are provided for inspection of a tire for hidden irregularities and defects. The apparatus includes a remotely located control console to protect electronic components from contamination and debris associated with tire retreading and from mechanical vibration associated with handling and inspecting used tire casings. The apparatus includes a tire supporting and rotating assembly, a receiver control assembly, a moveable transmitter assembly for directing energy against a tire and a movable receiver assembly to receive energy passing through the tire. Components of the mechanical system used to control movement of the receiver assembly are spaced from components of the mechanical system which support and rotate the tire
Patent NZ-510956-A (NZ)
Title: Preparation of wort and beer of high nutritional value, and corresponding products
Inventor: TRIANTAFYLLOY ANGELIKI OSTE
IPC: A23L7/104
Filed: 1999-10-22
Abstract: In a process for the production of a cereal beer made from a cereal or mixture of cereals an aqueous cereal slurry is prepared from wet milled rolled or crushed cereal, heat treated cereal flour, and their mixtures. The slurry is malted at a temperature above 50 DEG C in the presence of starch degrading enzymes and, optionally, protein degrading enzymes. Degradation of soluble beta - glucan is avoided by controlling beta -glucanase activity. Upon cooling insoluble material is removed to form a cereal wort which is boiled with hops to destroy any beta - glucanase activity. Substantial amounts of boiled traditional wort may be added during the process. Fermentation of the wort produces a beer containing a high amount of soluble beta -glucan. Also disclosed are products prepared by the process.
Patent NZ-512565-A (NZ)
Title: Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
Inventor: KONRADI ANDREI W
IPC: A61P3/00
Filed: 2000-01-21
Abstract: Disclosed herein are compounds that bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. These compounds can also be USED for the treatment of inflammatory brain diseases such as multiple sclerosis.
Patent NZ-512585-A (NZ)
Title: Tumor necrosis factor antagonists and their use in endometriosis
Inventor: BORRELLI FRANCESCO
IPC: C07K16/24
Filed: 2000-01-19
Abstract: A TNF sequestering antagonist selected from TNF receptor molecules or anti-TNF antibodies are used in the manufacture of a pharmaceutical composition for treating endometriosis or improve the implantation and fertility rate by reducing endometric lesions.
Patent NZ-512749-A (NZ)
Title: IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides
Inventor: SIMS JOHN ERNEST
IPC: C07K16/24
Filed: 1999-12-14
Abstract: Isolated polynucleotides encoding interleukin-1 zeta (IL-1 zeta), IL-1 zeta splice variants and Xrec2 polypeptides, processed for the production of recombinant forms of the polypeptides, antibodies generated against the polypeptides and their uses.
Patent NZ-517960-A (NZ)
Title: Method for minimising the new water use in the water circulation system of a treatment plant
Inventor: BENDER MARTIN
IPC: C02F9/14
Filed: 2000-09-26
Abstract: The invention relates to a method for minimising the new water use in the water circulation system of a treatment plant. The material to be treated is purified and/or disintegrated by means of water in a treatment step. The suspension containing the remaining components is subjected to mechanical purification and the mechanically purified suspension is separated into two process water streams. The first process waters stream is supplied back into the treatment step and the second process water stream is subjected to a chemical-physical clarification. The chemically-physically clarified process water stream is separated into two clear water streams. The first clear water stream is led into one of the two process water streams and/or into the suspension and the second clear water stream is subjected to a biological clarification. The biologically clarified clear water stream being a fresh water stream is led in one or two clear water stream/s. The ratio between the process water streams and the clear water streams has been determined before according to the material that is supplied to the treatment step and the kind of the mechanical purification and the kind of the chemical-physical clarification.
Patent NZ-520623-A (NZ)
Title: Steam heater
Inventor: DE JONG PETER
IPC: A23L7/10
Filed: 2001-02-05
Abstract: The invention relates to a device for treating a fluid product (4) such as a dairy product, with heat (6), the product (8) being transported with steam through a product conduit for treating the product with heat coming from the steam, the product treated with heat being subsequently supplied to an expansion tank (10) for cooling the product.
Patent NZ-521056-A (NZ)
Title: Interactive wagering system with wireless wagering capabilities
Inventor: ZARING JON C
IPC: G06Q50/34
Filed: 2001-02-28
Abstract: To submit electronic wagers on races, computer equipment is used to connect to a communications network using an interactivity wagering application. For this, in-home user equipment (146) and at least one wireless portable computing device (148) having a display device are implemented. The user is provided with on-screen options on the wireless portable computing device (148) to create a wager. Any choices made are then wirelessly transmitted (44r) to the in-home equipment (146), which are then sent down the communications network (140) for processing. Alternatively, the choices from the wireless computing device can also be sent wirelessly, using WAP (44q), straight to the communications network (140).
Patent NZ-523080-A (NZ)
Title: Antibodies specific for interleukin-1 alpha and interleukin-2 beta and methods of making and using
Inventor: COLLINSON ALBERT
IPC: A61K47/48
Filed: 2001-06-28
Abstract: A dual-specificity antibody or antigen-binding portion thereof specifically binds interleukin-1alpha and interleukin-1beta wherein the antibody is not a fully mouse antibody. The antibody can be used in diagnostic methods for detecting IL-á or IL-â and in the manufacture of a medicament for treating interlauikin-1-related disorders such as inflammatory disorder, autoimmune disorder i.e. rheumatoid arthritis, Crohn's disease, multiple sclerosis, insulin dependant diabetes mellitus and psoriasis. Methods of obtaining dual-specificity antibodies and methods of making an antibody are also described.
Patent NZ-524926-A (NZ)
Title: Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di-amino acid salts, and mono- and di-amino acid ester salts, and their use in modulating tumour growth
Inventor: VENIT JOHN J
IPC: C07D233/61
Filed: 2001-09-12
Abstract: Disclosed herein are combretastatin A-4 prodrug salts that increase the solubility of combretastatin A-4, readily regenerate combretastatin A-4 in vivo under normal physiological conditions, and which produce physiologically tolerable products as a result of the regeneration of combretastatin A-4.
Patent NZ-525466-A (NZ)
Title: Method and composition for washing poultry during processing
Inventor: HILGREN JOHN D
IPC: A23L13/50
Filed: 2001-10-29
Abstract: The present invention relates to compositions including mixture of peroxycarboxylic acids, such as peroxyacetic acid and peroxyoctanoic acid, and methods for reducing microbial contamination on poultry. The methods include the step of applying a mixed peroxycarboxylic acid composition to poultry, recovering and recycling the used solution by adding a mixture of fresh peroxycarboxylic acids and using again.
Patent NZ-526654-A (NZ)
Title: Levelling system and method for off-road vehicles
Inventor: ISLEY EMORY REGGALD
IPC: E02F9/02
Filed: 2000-12-04
Abstract: An off-road vehicle (10) has an undercarriage (11) and a superstructure and a tilting mechanism (15) for levelling the superstructure. The tilting mechanism comprises upper (30) and lower (40) members coupled to tilt about a tilt axis (33) by a hinge. The lower member (40) is pivotally mounted to the undercarriage (11). A brake (not shown) allows the orientation of the tilt axis relative to the undercarriage to be locked. The tilt mechanism allows the superstructure to be levelled by a method which includes the steps of releasing the brake (not shown), rotating the lower member until the tilt axis (33) is horizontal, and tilting the upper member (30) about the tilt axis until the superstructure (14) is level. The tilting mechanism is simple and provides a full range of tilt in all directions. A tilting mechanism may be retrofitted to existing vehicles.
Patent NZ-529023-A (NZ)
Title: Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
Inventor: COUPLAND KEITH
IPC: C07C231/10
Filed: 2002-05-20
Abstract: A compound of formula the formula CH3-(CH2)7-CH=CH-(CH2)13-C(O)-NH-(X)-COOR is described wherein: R is H or C1-6 alkyl and X is defined such that -NH-(X)-COOH is the residue of an amino acid, which amino acid may itself optionally be substituted at any pendant group thereof by a residue of a carboxylic acid or a derivative thereof. A pharmaceutical composition comprising the compound can be used as an anti-inflammatory and/or immunomodulatory agent.
Patent NZ-536306-A (NZ)
Title: Injection device
Inventor: MARTIN JEFFREY
IPC: A61M5/315
Filed: 2003-05-02
Abstract: An injection device for use with a syringe (30) having a bore (32) extending from an end surface (34), a needle (36) communicating with the bore through the end surface and a dispensing piston (38) movable in said bore towards said end surface so as to expel the content of the syringe through the needle, the injection device including a housing (60) having an opening (64) at one end through which the needle may extend, a resilient member for biassing the syringe and needle inwardly of the housing, a drive element (66) movable towards said one end so as to move the needle of the syringe out of the opening against the bias of the resilient member and to move the dispensing piston of the syringe towards the end surface, a delatch mechanism (72) operable to release the syringe such that the needle moves inwardly of the housing, a drive coupling (40) for extending from said drive element to the dispensing piston of the syringe so as to transfer movement of said drive element to the dispensing piston, wherein the drive coupling gradually reduces in length such that, after the drive element has moved the dispensing piston to the end surface, the drive element continues to move to said predetermined piston to the end surface, the drive element continuous to move to said predetermined position at which said delatch mechanism releases the syringe.
Patent NZ-536433-A (NZ)
Title: Pharmaceutical formulations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid
Inventor: CAMERON NORMAN EUGENE
IPC: A61P25/28
Filed: 2000-02-01
Abstract: A pharmaceutical combination comprising the HMG CoA reductase inhibitor (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid, and the ACE inhibitor lisinopril. The combination is used for the treatment of diabetic neuropathy and improving nerve conduction velocity or nerve blood flow in patients who have diabetic neuropathy.
Patent NZ-537574-A (NZ)
Title: Gaming machine with feature trigger
Inventor: STEVENS CHRISTOPHER
IPC: A63F13/10
Filed: 2003-07-07
Abstract: A gaming machine is provided. The machine has a display and a control means. The control means controls images of symbols on the display to play a random event game. If a predefined winning event occurs, the machine awards a prize, and if a number of die symbols are displayed at least two of the die symbols change to reveal outcomes, at least one of these outcomes results in the awarding of a feature. (61) Addition to 513431
Patent NZ-537667-A (NZ)
Title: A valve for closing a container, container and a system and method for filling a container
Inventor: FUNT MARK
IPC: F16K31/122
Filed: 2003-06-20
Abstract: A valve for closing a container and for enabling the container to be filled has a housing (20) with an inlet port (30) and an outlet port (40). A closing member (60) is provided for sealingly closing the valve at the inlet port (30). At least one valve member (70) is provided for controlling fluid communication between the inlet port (30) and the outlet port (40). The valve member only allows fluid communication when it is in a first position. The valve member (70) is designed in such a way that it is brought into and maintained in said first position only if a predetermined filling condition is achieved. The filling condition is typically achieved, when the filling pressure of a system for filling the container (50) is initially below a first predetermined or predeterminable threshold value.
Patent NZ-541262-A (NZ)
Title: Product handling for retail distribution
Inventor: JOHNSON MARTYN
Filed: 2005-07-15
Abstract: Disclosed is a product handling system for transferring products supported on a pallet with a slip sheet having a plurality of separable sections interposed between the pallet and the products, the separable sections supporting predetermined portions of the product on the pallet. The system includes a mobile product support means, a product transferring means having means to grip an edge of a separable section of the slip sheet and having means for transferring the slip sheet section and the products supported thereon from the pallet to the mobile product support while it is associated with the product transferring means, for subsequent handling or display of the products supported on the mobile support.
Patent NZ-541340-A (NZ)
Title: Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
Inventor: AVELLA ANTHONY
IPC: A61K35/14
Filed: 2004-01-29
Abstract: Disclosed is a substantially tetramer free haemoglobin solution and a method for its production involving polymerising a solution of haemoglobin, heat treating the polymerised haemoglobin solution to partially degrade the polymer to tetramer and removing tetramer from the haemoglobin solution.
Patent NZ-541601-A (NZ)
Title: HIV replication inhibiting pyrimidines and triazines
Inventor: GUILLEMONT JEROME EMILE GEORGE
IPC: C07D239/48
Filed: 2004-02-20
Abstract: Disclosed are pyrimidine derivatives of formula I wherein the substituents are as defined in the specification, having HIV (Human Immunodeficiency Virus) replication inhibiting properties.
Patent NZ-541914-A (NZ)
Title: Methods and apparatus for varying the back-up rate for a ventilator
Inventor: BASSIN DAVID JOHN
IPC: A61M16/00
Filed: 2004-03-05
Abstract: A ventilator device delivers ventilatory support to a patient in a back up timed mode (22) when patient respiration is not detected or a spontaneous mode when patient respiration is detected (20). The timing threshold (18) governing the back-up mode is chosen to deviate from normal expected respiration time for the patient to promote patient initiated ventilation in the spontaneous mode but permit back-up ventilation in the event of apnea. Automated adjustments (28, 30) to the timing threshold during the timed mode are made from the less vigilant timing threshold to a more vigilant threshold at or near a timing of normal expected breathing of the patient. Such adjustments may be made from a minimum to a maximum vigilance timing settings or incrementally there between as a function of time in the timed mode which is preferably the number of delivered machine breaths.
Patent NZ-550420-A (NZ)
Title: Systems and methods for automatically determining concentrations of exposure
Inventor: CHEN HAN
IPC: G16H50/30
Filed: 2005-03-11
Abstract: A method for automatically determining financial exposure of a geographical region of interest is provided. The method includes the steps of: storing and organising location and exposure data for a number of exposure locations in a database; defining a region of interest including a geographic area using an input means; creating a grid including a number of grid cells for the region of interest ,where each grid cell includes zero, one or more of the exposure locations; defining a boundary type for an area of analysis; automatically iteratively positioning the area of analysis throughout the region of interest, where each position includes a number of grid cells ; and determining a financial exposure for each positioned area of analysis from the iterative positioning step.
Patent NZ-552140-A (NZ)
Title: Blood pressure lowering protein hydrolysates
Inventor: EDENS LUPPO
Filed: 2005-07-12
Abstract: Disclosed is a process to produce IPP from a protein source whereby the ratio of IPP and VPP produced from the protein is at least 5:1, preferably at least 10:1 and more preferably at least 20:1, which comprises the use of a proline specific endoprotease and an enzyme that is capable of hydrolysing the bond at the amino terminal side of a -IPP- sequence.
Patent NZ-553599-A (NZ)
Title: Bagging machines and bags made thereby
Inventor: JOHNSTONE PETER
IPC: B65D30/10
Filed: 2005-08-03
Abstract: The specification discloses bag making apparatus for making a tube from plastics material web material and for making bags therefrom, the apparatus (10) including a support frame (11) defining a desired internal area of the tube formed thereon, first plastics material film web dispensing means (26, 27, 28, 29) for dispensing first film webs (30) in a longitudinal direction relative to the support frame (11) such that the film webs (30) overlap and adhere to one another, a second plastics material film web dispensing means (31) for laying at least one further film web (32) in overlapping spirals over the longitudinally extending first film webs (30), and a third plastics material film web dispensing means (34, 35, 36, 37) for dispensing third film webs (38) in a longitudinal direction relative to the support frame (11) over the overlapping spiral web material (32), the apparatus further including movement conveyor means (15) extending longitudinally of the support frame (11) to enable the tube formed thereon to be moved to a discharge region and transverse tube sealing means (21) and associated transverse tube separation means (23).
Patent NZ-553919-A (NZ)
Title: 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists
Inventor: LIM SUNGTAEK
IPC: C07D239/46
Filed: 2005-10-14
Abstract: Disclosed is a pyrimidine compound of Formula (I) wherein Cy1 is cycloalkyl, heterocycIyl, cycloalkenyl, heterocyclenyl, heteroaryl, aryl, or multicyclic alkaryl. Cy2 is cycloalkenyl, heterocyclenyl, aryl, heteroaryl, or multicyclic alkaryl. L1 is a straight- or branched-chain alkylene or a -CH2-haloalkylene, or is cycloalkylene or L1 and Cy2 together represent arylcycloalkyl or cycloalkylaryl. R1 is alkoxy, L2 is bond, -O- or -CH2-O- and wherein R2, R3, R4 and R5 are each independently H or alkyl. R6 is alkyl, R7 is H or alkyl and R8 is alkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl. Y1 and Y2 are each independently hydrogen, or alkyl or Y1 and Y2 taken together with the nitrogen atom to which they are attached, form a nitrogen containing three to seven member saturated heterocyclyl. Z1 is C(=O)-N(R4), NR4 or S(O)n and n is 0, 1 or 2 or an N-oxide thereof and R4 is as defined in the specification, or an ester prodrug thereof, or a pharmaceutically acceptable salt, hydrate, or solvate thereof. Also disclosed are pharmaceutical compositions comprising said compound and the use of said compound in the manufacture of a medicament for the treatment of an allergic disorder e.g. asthma.
Patent NZ-556129-A (NZ)
Title: Guiding device for neck ring of a glassware making machine where runners on a center body are used to align the two halves
Inventor: FLYNN ROBIN L
IPC: C03B9/34
Filed: 2005-12-07
Abstract: A neck ring guide for aligning neck ring sections in a glassware forming machine is disclosed. The guide has a center body (44) and a pair of spaced parallel runners (46, 48) coupled to the center body for receipt in guide slots in the neck ring sections. Keepers (50) on the outboard sides of the runners (46, 48) retain the runners (46, 48) in the guide slots. Instead of keepers (50), the runners (46, 48) may be retained in the guide slots by roll pins on the neck ring sections engaged in retainer slots in the runners.
Patent NZ-556684-A (NZ)
Title: Permeate spacer module
Inventor: HEINEN NICOLAS
IPC: B01D63/00
Filed: 2006-02-23
Abstract: A membrane plant comprises a membrane system 14, which comprises a permeate spacer module comprising a spacer 1 with membrane films, leaves or sheets 6 partly welded or glued on both sides of the spacer 1, one or two permeate collection devices 15, and a collection tank or container or well 17. The spacer 1 comprises inserted elements 4 and support members 2 selected from a group consisting of solid surface material(s) having perforations, porous surface material(s), composite surface material(s) having perforations or pores or combinations thereof, and sandwich surface material(s) having perforations or pores, or combinations thereof. The support members 2 are separated by inserted element 4 thus forming flow channels 5 between the support members 2 and the inserted element 4 for guiding permeates to the permeate collection devices 15 connected or attached to the spacer 1. The flow channels 5 are parallel to each other and perpendicularly connected or attached to the permeate collection devices 15. The permeate collection device 15 is an expanded frame of tubular form or of U-shaped extruded form. The membrane system 14 is placed in a biological treatment tank and the collection tank, or the container, or the well 17 is connected to the membrane system by the permeate collection devices 15. The permeates are transferred by hydrostatic pressure from the permeate collection devices 15 to the collection tank, or to the container, or to the well 17.
Patent NZ-560485-A (NZ)
Title: Methods of treating cancer with HDAC inhibitors
Inventor: BACOPOULOS NICHOLAS G
IPC: A61K31/16
Filed: 2004-08-26
Abstract: Disclosed is the use of suberoylanilide hydroxamic acid (SAHA) of formula I or a pharmaceutically acceptable salt or hydrate thereof, and a pharmaceutically acceptable carrier or diluent, for the preparation of a medicament for administration to a subject for treatment of follicular lymphoma.